CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Net Income Growth by Quarter and Year

Atara Biotherapeutics,'s Net Income results by quarter and year




ATRA Net Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - -35.31 -18.24 -21.25
III Quarter September - -31.10 -25.37 -11.87
II Quarter June -50.88 -27.43 -18.88 -14.95
I Quarter March -41.44 -25.65 -16.56 -9.16
FY   -92.32 -119.49 -79.05 -57.23



ATRA Net Income second quarter 2018 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the second quarter recorded net loss of $ -50.88 millions.

According to the results reported in the second quarter, Atara Biotherapeutics, Inc. achieved the best Net Income growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s Net Income no change of % ranks overall at the positon no. in the second quarter.




ATRA Net Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s second quarter 2018 Net Income $ -50.88 millions ATRA's Income Statement
Atara Biotherapeutics,'s second quarter 2017 Net Income $ -27.43 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Net Income Growth >>


ATRA Net Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income second quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018
You need to upgrade your Flash Player

Atara Biotherapeutics,'s Q/Q Net Income Growth


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q Net Income Comment
Recent accomplishment of -50.88 millions by Atara Biotherapeutics, Inc. appear even less good if you take a look at -41.44 millions in the previous quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Net Income growth. While Atara Biotherapeutics,'s Net Income growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
Cumulative Net Income 12 Months Ending $ -158.74 $ -135.28 $ -119.49 $ -102.41 $ -96.69
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months net loss of $ -159 millions in the Jun 30 2018 period.
The results are detiriorating as the cumulative net loss is getting bigger from $ -135.28 millions in TTM ending quarter Mar 31 2018 and $ -41.44 millions for the twelve months ending in the quarter Jun 30 2017 Mathias Janssens told.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


You need to upgrade your Flash Player




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ATRA's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ATRA's Competitors
Net Income Growth for Atara Biotherapeutics,'s Suppliers
Net Income Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Jun 30 2018 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2018
Abiomed Inc  140.99 %$ 140.986 millions
Prestige Brands Holdings, Inc.  139.72 %$ 139.717 millions
National Healthcare Corp  111.70 %$ 111.704 millions
U S Physical Therapy Inc  107.14 %$ 107.136 millions
Avanos Medical, Inc.  106.43 %$ 106.433 millions
Davita Inc.  89.53 %$ 89.526 millions
Lemaitre Vascular Inc  88.92 %$ 88.925 millions
Ensign Group, Inc  80.34 %$ 80.339 millions
Supernus Pharmaceuticals Inc  76.97 %$ 76.975 millions
Inogen Inc  75.22 %$ 75.222 millions
Medpace Holdings, Inc.  73.43 %$ 73.432 millions
Amyris, Inc.  72.10 %$ 72.097 millions
Imprimis Pharmaceuticals, Inc.  69.95 %$ 69.946 millions
Cambrex Corp  61.48 %$ 61.482 millions
Innoviva, Inc.  61.09 %$ 61.088 millions
Zynex Inc  60.77 %$ 60.771 millions
Addus Homecare Corp  59.15 %$ 59.148 millions
Jrsis Health Care Corp  56.50 %$ 56.504 millions
Align Technology Inc  53.38 %$ 53.377 millions
Edwards Lifesciences Corp  51.91 %$ 51.908 millions
Lhc Group, Inc  45.54 %$ 45.537 millions
West Pharmaceutical Services Inc  44.59 %$ 44.588 millions
Corcept Therapeutics Inc  43.88 %$ 43.876 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TILE's Profile

Stock Price

TILE's Financials

Business Description

Fundamentals

Charts & Quotes

TILE's News

Suppliers

TILE's Competitors

Customers & Markets

Economic Indicators

TILE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071